8-K
filed April 24, 2025, 7:59 PM ET
ticker VRRM
CIK 0001682745
other
confidence high
sentiment neutral
materiality 0.30
Verra Mobility adopts new Annual Incentive Plan for 2025, replacing prior short-term plan
VERRA MOBILITY Corp
- New AIP effective Jan 1, 2025; supersedes Second Amended and Restated Short-Term Incentive Plan.
- Bonuses based on company performance factors (e.g., adjusted EBITDA, revenue) and individual performance multiplier.
- Bonuses require achievement of an EBITDA threshold before any company-performance-based payout.
- Participants include named executive officers; Compensation Committee approves targets for CEO and ELT.
- Plan may be amended or terminated at any time by Compensation Committee.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0000950170-25-058093
- form_type
- 8-K
- ticker
- VRRM
- cik
- 0001682745
- company_name
- VERRA MOBILITY Corp
- filed_at
- 2025-04-24T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:49.328544+00:00
- generated_at
- 2026-05-23T07:07:31.932935+00:00
- sec_items
- ["5.02", "9.01"]
- event_type
- other
- sentiment
- neutral
- materiality_score
- 0.3
- calibrated_materiality_score
- 0.3
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0000950170-25-058093
- json_url
- https://secwatch.observer/filing/0000950170-25-058093.json
- markdown_url
- https://secwatch.observer/filing/0000950170-25-058093.md
- text_url
- https://secwatch.observer/filing/0000950170-25-058093.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1682745/000095017025058093/0000950170-25-058093-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1682745/000095017025058093/vrrm-20250423.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
EDSA
Edesa Biotech shareholders approve equity plan amendment adding 750K shares
Edesa Biotech, Inc.
May 29, 2026, 4:15 PM ET
other
Items 5.02, 5.07, 9.01
same SEC item: 5.02, 9.01
same event type: other
similar materiality
Filing page
SEC filing
HAFC
Director Gideon Yu resigns from Hanmi board; stockholders approve 2026 ESPP
HANMI FINANCIAL CORP
May 27, 2026, 6:15 PM ET
other
Items 5.02, 5.07, 9.01
same SEC item: 5.02, 9.01
same event type: other
similar materiality
Filing page
SEC filing
PAL
Proficient Auto Logistics to attend William Blair conference; sets Q2 2026 earnings call for Aug 10
Proficient Auto Logistics, Inc
June 1, 2026, 5:29 PM ET
other
Items 7.01, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
REVB
Revelation Biosciences releases updated corporate presentation without disclosed details
REVELATION BIOSCIENCES, INC.
June 1, 2026, 5:26 PM ET
other
Items 8.01, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
XBP
XBP Global Holdings annual meeting elects directors, approves auditor and say-on-pay
XBP Global Holdings, Inc.
June 1, 2026, 5:00 PM ET
other
Items 5.07, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
SCHW
Charles Schwab files Certificate of Elimination for Series I Preferred Stock
SCHWAB CHARLES CORP
June 1, 2026, 5:00 PM ET
other
Items 5.03, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
AXON
Axon shareholders elect all 9 director nominees and approve say-on-pay at 2026 annual meeting
AXON ENTERPRISE, INC.
June 1, 2026, 4:10 PM ET
other
Items 5.07, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
ILPT
ILPT posts investor presentation with property highlight but no financial updates
Industrial Logistics Properties Trust
June 1, 2026, 4:05 PM ET
other
Items 7.01, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.